Original paperConversion factors to estimate effective doses from kerma area product in interventional cardiology. Impact of added filtration
Introduction
The X-ray systems used for interventional procedures are able to give patient exposure indexes during and at the end of the procedures. In the most recent models, the X-ray systems are able to transfer this dosimetric and other technical and geometrical information to the DICOM radiation dose structured reports (RDSR).
The dosimetric data, kerma area product –KAP– and air kerma –AK– at the patient entrance reference point [1], are used for optimisation of the radiation protection of patients. Now, with the information contained in the RDSR (kV, filtration, C-arm angulation, radiation field size, etc) the optimisation actions may be improved. For specific clinical indications, their median values should be periodically compared with the diagnostic reference levels (DRLs) [2].
Population doses are estimated using the frequency of the procedures and the quantity effective dose. The Monte Carlo software [3] allows organ and effective doses to be calculated from the primary dosimetric quantities reported by the X-ray systems, from all the information on the X-ray beam quality (kV and filtration) and from other geometrical and technical factors.
According to the recommendations of the International Commission on Radiological Protection (ICRP), effective doses should not be used to estimate individual radiation risks to patients but may be useful to compare the relative risks when different imaging procedures with different modalities (e.g. X-ray catheterization, computed tomography and nuclear medicine) are performed on the same patient [4], [5].
The new European Directive on Basic Safety Standards [6] requires patient dose audits and the use of DRLs for optimisation, and in addition, this regulation requires that “population doses derived from medical exposures be estimated for radiodiagnostic and interventional radiology”. Such a requirement makes it necessary to estimate effective doses and the frequency of the procedures.
The UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) collects and periodically publishes the worldwide data on population doses arising from medical exposures. The last global report for the data corresponding to the period 1997–2007 was published in 2008 [7] and the next report is expected in 2020.
UNSCEAR recognises that there are some limitations to the survey data as the majority of responses received come from the relatively more developed countries. Principally because of their numerous significant benefits, interventional radiology and cardiology procedures have experienced a dramatic increase in frequency in recent years. The UNSCEAR report of 2008 stated that the average conversion factor to deduce the effective dose from KAP readings for cardiac interventional procedures was 0.17 mSv/(Gy.cm2) [7].
In 2015, UNSCEAR published in view of the next report, a “User Manual for the Global Survey on Medical Exposures” [8] in which it is indicated that “effective dose estimation is usually performed using simpler methods on the basis of easily measurable dose metrics and the application of conversions coefficients that have been determined through scientific research”.
The factors recommended in this manual for the estimation of effective doses in cardiac interventional procedures were: 0.12 mSv/(Gy.cm2) for diagnostic coronary angiography and a wide range of factors from 0.20 to 0.28 for percutaneous transluminal coronary angioplasty (PTCA) [8].
In Europe, all the interventional procedures are estimated to contribute 3.5–14%, to the collective dose and the PTCAs, 0.5–3.6% [9]. In the latest European report, published in 2015 [10], the contribution of interventional radiology to the total collective dose in medical imaging in Europe was estimated 8–9% with a mean value in frequency of 0.6%. For coronary angiography and coronary angioplasty, in many countries, the effective dose is being estimated by multiplying the KAP by 0.2 mSv/(Gy.cm2), a factor recommended by the European Guidelines for adult patients in IC (interventional cardiology) [9].
In Spain, the fraction of the collective dose per million inhabitants derived from IC was 34 man-Sv (1600 man-Sv in Spain with 46.5 million inhabitants). The frequency of the IC procedures in Spain is 0.66% from the total medical procedures with X-rays, and IC represents 4% of the X-ray collective dose. These estimations result from the information on frequencies of examinations sourced from the Spanish Society of Cardiology and the patient dose values obtained by the national programme on patient dose DOCCACI [11].
The patient dose management systems already introduced in many hospitals allow to collect the dosimetric data, together with other technical details and geometrical data automatically for each radiation event (fluoroscopy and cine runs) of the interventional procedures. Consequently, a more detailed Monte Carlo calculation can be made to estimate organ and effective doses for a large number of patients.
Another importance issue is that some new X-ray systems dedicated to interventional procedures are implementing patient dose reduction techniques with different X-ray beam qualities (higher Cu filtration) and with advanced post-processing of the images, which may lead to a substantial variation in the conversion factor to estimate effective doses.
It seems appropriate to revisit and update these conversion factors.
The aims of this paper are:
- •
To calculate the conversion factors (using all the information contained in the RDSR for each of the radiation events), to estimate effective doses from KAP values, using a large number of cardiac procedures and Monte Carlo software.
- •
To evaluate the impact of the added copper filtration in the X-ray beams on these conversion factors, and to give practical advice for the evaluation of the collective doses derived from IC.
Section snippets
Materials and method
We have used the data of all the interventional cardiac procedures performed during the year 2018 in two interventional cardiology laboratories in a large university hospital in Madrid.
The two cardiac laboratories are equipped with Philips Allura interventional systems: room 3 (used for the most standard diagnostic and therapeutic procedures) with the Allura X-PER X-ray system, and room 5, with a “Clarity” version of the Allura system (the new patient dose reduction system from Philips). This
Results
Fig.1, Fig. 2 present the results for catheterisation room 3 (standard X-ray system) for all the clinical procedures (coronary angiographies and PTCAs) performed during 2018. There are, of course, in the sample, procedures with different complexity levels, with different percentages of fluoroscopy and cine modes and patients with different weights. But the sample is large enough (54,373 radiation events and 758 procedures) to consider the conversion factor calculated (ratio between effective
Discussion
The conversion factors obtained in this paper may be useful to update the previous existing values obtained several years ago and used by NCRP and UNSCEAR [7], [8], [9]. In some cases, the factors in these documents were obtained with small samples and without taking into account the relevant impact of the copper filtration in the X-ray beam more used in the current interventional systems.
Fig. 2, Fig. 4 present global factors for cardiac procedures performed with:
- •
Standard X-ray system and
Limitations
The conversion factors reported in this paper have been obtained from a large number of standard clinical procedures of interventional cardiology performed with two X-rays systems with local settings and local operation protocols. The results obtained with other X-ray systems or with different protocols could need some refinement concerning these factors.
Conclusions
The conversion factors we calculated to estimate effective doses from the KAP values supplied by the X-ray systems currently used for interventional radiology, resulted in 0.21 ± 0.05 (using copper filtration for fluoroscopy and no copper filtration for cine) and 0.29 ± 0.03 for the new X-ray systems with patient dose reduction techniques, using copper filtration for cine and fluoroscopy.
The new X-ray systems with patient dose reduction techniques usually use added copper filtration for cine, a
Acknowledgments
This work has been partially founded by the Spanish Ministry of Economy and Competitiveness (Instituto de Salud Carlos III) and European Regional Development Fund (ERDF) under the project MEDICI number PI16/01413 and the Spanish National Safety Council under the project EDOCI.
There are no actual or potential conflicts of interest to declare in relation to this paper.
References (28)
- et al.
Reducing radiation dose in coronary angiography and angioplasty using image noise reduction technology
Am J Cardiol
(2016) - et al.
Establishing the European diagnostic reference levels for interventional cardiology
Phys Med
(2018) - et al.
Pifarré X. DOCCACI Group. Initial results from a national follow-up program to monitor radiation doses for patients in interventional cardiology
Rev Esp Cardiol (Engl Ed)
(2014) - et al.
Conversion factors of effective and equivalent organ doses with the air kerma area product in patients undergoing coronary angiography and percutaneous coronary interventions
Phys Med
(2017) - International Electrotechnical Commission (IEC). Medical electrical equipment – Part 2–43: Particular requirements for...
- ICRP-135. Diagnostic Reference Levels in Medical Imaging. ICRP Publication 135. Ann. ICRP 2017; 46(1):...
- Tapiovaara M, Siiskonen T. PCXMC: A Monte Carlo program for calculating patient doses in medical X-ray examinations...
- ICRP-103. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103....
Radiological protection in medicine. ICRP Publication 105
Ann ICRP
(2007)- European Council. Council Directive 2013/59/Euratom of 5 December 2013, laying down basic safety standards for...
Cited by (8)
Conversion factors for effective dose and organ doses with the air Kerma area product in hysterosalpingography
2021, Physica MedicaCitation Excerpt :The present study was motivated by the lack of reliable conversion factors for HSG procedures established using posteroanterior geometry of irradiation and systems equipped with digital detectors, which can be considered as state-of-the-art methodology and technology. Moreover, all the publications related to HSG dosimetry provided a single value for the E/KAP conversion factor, whilst as we demonstrated in the present work and was previously reported for interventional cardiology procedures [19] or biliary procedures [20] the conversion factors critically depend on the amount of beam filtration which is employed in the single episodes of irradiation. E should not be interpreted as a precise quantity.
Conversion factors for effective dose and organ doses with the air kerma area product in patients undergoing percutaneous transhepatic biliary drainage and trans arterial chemoembolization
2020, Physica MedicaCitation Excerpt :This conversion factors could be incorporated in look up tables inside the Radiation Dose Monitoring Systems to provide accurate estimates of E and HT without the need of reverting to specific software for performing individual dose estimations. Moreover, this procedure could be easily extended to other equipment provided with different Cu filtration by simple interpolation of the conversion coefficient values or by using the polynomial fitting equation provided in Fig. 1 for biliary procedures or similar sets of conversion factors specifically derived in for other interventional procedures [19]. The conversion factors reported in the paper have been established in many biliary procedures performed with a single X-ray interventional system using local settings and acquisition protocols.
Use of secondary air kerma from dose area product and fluoroscopy time for preventive effective dose estimation in interventional radiology procedures for staff
2023, Journal of Radiological ProtectionDosimetric quantities and effective dose in medical imaging: a summary for medical doctors
2021, Insights into ImagingPatient doses and cancer risks in fluoroscopy and interventional radiology procedures
2021, AIP Conference Proceedings